Evaluating the In Vitro Activity and Safety of Modified LfcinB Peptides as Potential Colon Anticancer Agents: Cell Line Studies and Insect-Based Toxicity Assessments

[Image: see text] Anticancer peptides are increasingly being considered as alternative treatments for cancer due to their potency, selectivity, and low toxicity. Previously, the peptide LfcinB (21–25)(Pal) showed in vitro anticancer effects against the Caco-2 colon cancer cell line (half-maximal inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Cárdenas-Martínez, Karen J., Barragán-Cárdenas, Andrea C., de la Rosa-Arbeláez, Manuela, Parra-Giraldo, Claudia M., Ochoa-Zarzosa, Alejandra, Lopez-Meza, Joel E., Rivera-Monroy, Zuly J., Fierro-Medina, Ricardo, García-Castañeda, Javier E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586019/
https://www.ncbi.nlm.nih.gov/pubmed/37867694
http://dx.doi.org/10.1021/acsomega.3c03455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586019/
https://www.ncbi.nlm.nih.gov/pubmed/37867694
http://dx.doi.org/10.1021/acsomega.3c03455

Ejemplares similares